Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant720 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06123637 | Analgesia Nociception Index-guided Anesthesia and Standard Anesthesia | unknown | N/A | 68 | Ajou University School of MedicineOTHER | 0 | Nov 9, 2023 | clinicaltrials |
| NCT04223401 | Prehabilitation for Gastrectomy(PREFOG) | unknown | N/A | 128 | National Cancer Center Affiliate of Vilnius University Hospital Santaros KlinikosOTHER | 1 | Nov 8, 2023 |
| clinicaltrials |
| NCT06123455 | Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer | unknown | Phase 2 | 60 | Tang-Du HospitalOTHER | 1 | Nov 8, 2023 | clinicaltrials |
| NCT04198337 | Endoscopic Full Thickness Resection for Gastric GIST(EFTR) | unknown | N/A | 30 | Chinese University of Hong KongOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT03917173 | Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Gastric Carcinoma.GOETH Study(GOETH) | unknown | N/A | 240 | Mario Negri Institute for Pharmacological ResearchOTHER | 1 | Oct 26, 2023 | clinicaltrials |
| NCT06102746 | Clinical Study of Surufatinib Plus Sintilimab Combined With Chemotherapy in the Treatment of Advanced Gastric Neuroendocrine Carcinoma | unknown | — | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Oct 26, 2023 | clinicaltrials |
| NCT06098898 | Safety and Efficacy of NK510 to Treat Gastric Cancer | unknown | Early Phase 1 | 9 | Base Therapeutics (Shanghai) Co., Ltd.INDUSTRY | 1 | Oct 25, 2023 | clinicaltrials |
| NCT05229874 | Effect of CNSI vs. ICG in Lymph Node Tracing During Gastrectomy(FUTURE-01) | unknown | Phase 2 | 96 | Hebei Medical UniversityOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT03129139 | A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors(Minnelide 101) | unknown | Phase 1 | 66 | Minneamrita Therapeutics LLCINDUSTRY | 1 | Oct 18, 2023 | clinicaltrials |
| NCT05566834 | Minnelide™ Capsules Alone and in Combination With Paclitaxel in Advanced Gastric Cancer | unknown | Phase 1 | 36 | Minneamrita Therapeutics LLCINDUSTRY | 1 | Oct 18, 2023 | clinicaltrials |
| NCT06085677 | The Gastric HormonE BioMarkers of Preneoplastic Lesions Study(GEM) | unknown | — | 600 | Imperial College LondonOTHER | 0 | Oct 17, 2023 | clinicaltrials |
| NCT06078982 | Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric Cancer | unknown | Phase 1 | 39 | Shanghai East HospitalOTHER | 1 | Oct 12, 2023 | clinicaltrials |
| NCT04219332 | Randomized Controlled Trial on Effect of Lymph Node Mapping by Indocyanine Green Via Submucosal or Subserosal Injection | unknown | Phase 3 | 266 | Fujian Medical UniversityOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT06073483 | Exploratory Study of Toumai Endoscopic Surgery System for Remote Gastrectomy | unknown | N/A | 10 | Hebei Medical UniversityOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT06076265 | Quantitative Detection of CEA mRNA in the Smog and Tissue Exudate Whole Process Collected During Laparoscopic (Robotic) Radical Gastrectomy in Gastric Cancer Patients | unknown | — | 80 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT04943406 | Peritoneal Lavage Liquid Biopsy in Patients With Gastric Cancer(LIQUID) | unknown | — | 150 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Oct 6, 2023 | clinicaltrials |
| NCT03253107 | Predicting Biomarker of Gastric Cancer Chemotherapy Response | unknown | — | 800 | Kyungpook National University HospitalOTHER | 1 | Oct 4, 2023 | clinicaltrials |
| NCT02338518 | Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients(SVOSA) | unknown | Phase 3 | 297 | Jinling Hospital, ChinaOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT04033107 | High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors | unknown | Phase 2 | 30 | Zhongnan HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05566899 | Pilot Study of Stomach Cancer Early Detection and Prevention With Endoscopy | unknown | N/A | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06046846 | Prehabilitation Via a Mobile Application in Oesophago-gastric Cancer | unknown | N/A | 20 | Queen Margaret UniversityOTHER | 0 | Sep 21, 2023 | clinicaltrials |
| NCT06046963 | Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites | unknown | Phase 2 | 35 | Zhejiang Cancer HospitalOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06047158 | Effects of Omega-3 Fish Oil Fat Emulsion on Rehabilitation and Immune Function After Radical Surgery Combined With Intraperitoneal Hyperthermic Infusion Chemotherapy in Patients With Locally Advanced Gastric Cancer | unknown | — | 200 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06048458 | Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping(PC-TOX) | unknown | — | 75 | University College, LondonOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06033482 | The Possible Range of No.12a Lymph Node Dissection of Locally Advanced Gastric Cancer | unknown | — | 100 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT06034964 | Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC | unknown | — | 60 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT04184960 | AG & IM in CA Stomach Protocol | unknown | — | 400 | Chinese University of Hong KongOTHER | 4 | Sep 7, 2023 | clinicaltrials |
| NCT05447221 | Automatic Evaluation of the Severity of Gastric Intestinal Metaplasia With Pathology Artificial Intelligence Diagnosis System | unknown | — | 150 | Shandong UniversityOTHER | 1 | Sep 6, 2023 | clinicaltrials |
| NCT05795296 | Efficacy and Safety of Fruquintinib With Sintilimab as First-line Therapy in Gastric Cancer | unknown | Phase 2 | 30 | RenJi HospitalOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT06008925 | Clinical Study of VG161 Combined With Nivolumab Injection in Patients With Advanced Metastatic Gastric Cancer | unknown | Phase 1 / Phase 2 | 43 | CNBG-Virogin Biotech (Shanghai) Ltd.INDUSTRY | 1 | Aug 24, 2023 | clinicaltrials |
| NCT05997459 | A Single Arm, Phase II Exploratory Clinical Study of Pemitinib in Advanced Gastric Cancer With Previous Standard Therapy Failure the FGFR Variant | unknown | Phase 2 | 23 | Sun Yat-sen UniversityOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT05517408 | Dose Exploration of Ciprofol for Sedation in Gastrointestinal Endoscopic Diagnosis and Treatment of Obese Patients. | unknown | N/A | 30 | RenJi HospitalOTHER | 1 | Aug 16, 2023 | clinicaltrials |
| NCT05994456 | Neoadjuvant Toripalimab for dMMR/MSI-H Gastric Cancer | unknown | Phase 2 | 24 | Sun Yat-sen UniversityOTHER | 1 | Aug 16, 2023 | clinicaltrials |
| NCT05985577 | Mechanism of Gastric Signet Ring Cell Carcinoma Based on Microproteomics | unknown | — | 300 | Zhejiang Cancer HospitalOTHER | 1 | Aug 14, 2023 | clinicaltrials |
| NCT05235906 | A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric Cancer | unknown | Phase 2 | 61 | Sun Yat-sen UniversityOTHER | 1 | Aug 9, 2023 | clinicaltrials |
| NCT05688020 | Tranexamic Acid During Upper GI Endoscopic Resection Procedures | unknown | Phase 4 | 200 | Assaf-Harofeh Medical CenterOTHER_GOV | 1 | Aug 9, 2023 | clinicaltrials |
| NCT05982834 | Disitamab Vedotin, Fruquintinib and Tislelizumab in Second-line Treatment for HER2-positive MGC | unknown | Phase 1 / Phase 2 | 43 | Fudan UniversityOTHER | 1 | Aug 9, 2023 | clinicaltrials |
| NCT05982301 | Sintilimab Combined With Modified FLOT Regimen in the Treatment of Metastatic Gastric Cancer | unknown | Phase 2 | 87 | Fudan UniversityOTHER | 1 | Aug 8, 2023 | clinicaltrials |
| NCT05977478 | Characterization of Tissue Biochemical Composition in Gastric Precancerous/Cancerous Lesions | unknown | N/A | 25 | National University Hospital, SingaporeOTHER | 1 | Aug 4, 2023 | clinicaltrials |
| NCT05974059 | Cadonilimab Combined With CapeOX Regimen in Perioperative Treatment of Resectable Locally Advanced Gastric Cancer | unknown | Phase 2 | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT04250948 | Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric Cancer | unknown | Phase 2 | 108 | Sun Yat-sen UniversityOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05952375 | Exploratory Clinical Trial on the Safety, Efficacy, and Pharmacokinetics of XKDCT086 (iPD-1-Claudin18.2-CAR-T) in Claudin 18.2 Positive Advanced Solid Malignant Tumors: a Single Center, Single Arm, Dose-increasing Trial | unknown | N/A | 9 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Jul 19, 2023 | clinicaltrials |
| NCT05948449 | To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. | unknown | Phase 2 | 37 | Sichuan UniversityOTHER | 0 | Jul 17, 2023 | clinicaltrials |
| NCT05715632 | New Adjuvant Treatment of Locally Advanced Resectable Gastric Cancer With Carelizumab and XELOX | unknown | N/A | 46 | Tang-Du HospitalOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT05942573 | Continuation of Serplulimab Plus Chemotherapy After First Progression in Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma: an Open-label, Randomised Phase II Trial | unknown | Phase 2 | 107 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jul 12, 2023 | clinicaltrials |
| NCT04267549 | Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer | unknown | Phase 2 | 47 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jul 6, 2023 | clinicaltrials |
| NCT05928897 | Efficacy and Safety of Disitamab Vedotin Combined With Sintilimab | unknown | Phase 2 | 30 | Xiangya Hospital of Central South UniversityOTHER | 0 | Jul 5, 2023 | clinicaltrials |
| NCT05928819 | Evaluation of a Computer-aided Diagnosis System (CADx) in the Early Detection of Gastric Cancer in France. Cancer in France.(EGC-France) | unknown | — | 120 | Hospices Civils de LyonOTHER | 1 | Jul 3, 2023 | clinicaltrials |
| NCT05751265 | Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric Cancer | unknown | Phase 2 | 39 | Fujian Cancer HospitalOTHER_GOV | 0 | Jun 22, 2023 | clinicaltrials |
| NCT05901376 | MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection | unknown | — | 280 | King Chulalongkorn Memorial HospitalOTHER | 1 | Jun 13, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Nov 9, 2023source: clinicaltrials